EDGAR Filing Documents for 0001493152-24-014821

Form 8-K - Current report:

SEC Accession No. 0001493152-24-014821

Filing Date

2024-04-16

Accepted

2024-04-16 16:10:29

Documents

Period of Report

2024-04-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	60963
2		ex10-1.htm	EX-10.1	31337
3		ex10-2.htm	EX-10.2	183827
4		ex10-3.htm	EX-10.3	125759
5		ex10-4.htm	EX-10.4	103475
6		ex99-1.htm	EX-99.1	16635
7		ex99-1_001.jpg	GRAPHIC	2170
	Complete submission text file	0001493152-24-014821.txt		793786

Data Files

Seq	Description	Document	Type	Size
8	XBRL SCHEMA FILE	qlgn-20240411.xsd	EX-101.SCH	3009
9	XBRL LABEL FILE	qlgn-20240411_lab.xml	EX-101.LAB	34240
10	XBRL PRESENTATION FILE	qlgn-20240411_pre.xml	EX-101.PRE	22355
22	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3622

Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011

Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165

Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)